argyrotsipi/train-dataset huggingface dataset:
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): The answer to that question is, I do not know. It is possible that none will close. I do not believe that 3,000 will close. However, I would say this. The average operating margin that the pharmacy makes on the numbers that I quoted earlier is 15%. That is after salaries and rent. The cuts that we are making, or the efficiencies that we are asking for, are significantly lower than that. Of course there is no such thing as an average pharmacy, which is why I cannot guarantee that there will be no changes. What I can say is that, if there are mergers and if there is some consolidation, that demand does not go away—it goes to the other pharmacies in the cluster. To say that those pharmacies will be put under more pressure is plain wrong I say again that what we are doing is building an industry that is fit for the future, that is modern and that is adding value in a way it has not been able to do in the past.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Alan Haselhurst (Conservative, Centre-right): Does my hon. Friend the Minister acknowledge that the NHS has become such a part of the nation’s DNA that doctors’ surgeries are frequently overloaded, that absolutely the right way forward is to have a rational, well-spaced network of pharmacies and that that is of particular importance in rural areas?
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I do recognise that. My right hon. Friend made the point that the network is well spaced and that rural areas are protected. I would also make the point that, as I said in my statement, we are recruiting a further 1,500 pharmacists into the GP network. They will also play a big part in that integration.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): This year we invested a further £5 billion in the NHS, three times the rate of inflation. In June the OECD noted we are now above average in terms of NHS and social care spend in the OECD. However much we spend, it is right we look to do it as efficiently and effectively as possible, to modernise this service and make it better for patients, and that is what we are doing.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Anna Mary Soubry (Conservative, Centre-right): The Minister knows my views: I do not think this 4% cut is a wise move. But I do note—and it is important that everybody reports this accurately—that that money is going to stay within the NHS, so it is not a cut. Can the Minister assure us about any incentives for pharmacies in the delivery of public health measures, notably preventive measures?
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I thank my right hon. Friend for that comment and reassure her that for the first time we will be allowing pharmacists to access a quality fund, which means that the average pharmacy could earn up to £6,000 or £7,000 over and above what it gets just for dispensing. The fund will include specific measures around public health.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I thank the hon. Lady for her point. She mentioned Scotland’s minor ailments programme. The announcement I made on that about a week ago was in many ways modelled on the Scottish model, because we know that pharmacies can do much more on minor ailments than at present. That will be commissioned separately from the other things we are talking about today, and paid for separately from the integration fund. We are a little behind Scotland in that regard, and we are going to catch up.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Michael Andrew Gove (Conservative, Centre-right): I congratulate the Minister on recognising what Labour failed to: that NHS money is taxpayers’ money and the priority should always be patient care, not the profits of private equity firms. May I further congratulate him on making it clear that those living in our most deprived communities will be protected and have services enhanced as a result of this change, and may I invite him to say more?
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I will not say much more because of time constraints, but I thank my right hon. Friend for his comments. He is right to remind the House that this sector is quite concentrated towards public companies. That is not to say there are not some individual pharmacists that will be affected, but about 25% of pharmacies are owned by two or three public companies.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Edward Vaizey (Conservative, Centre-right): I congratulate the Minister on his statement. It is worth reminding the House that many urban pharmacies are located in clusters and are very close to one another. It is therefore quite right that we should look at how they are subsidised. I am pleased that, as a result of these savings, he will be looking out for rural pharmacies, which are more dispersed. They are the ones that really need the help.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): The access scheme to which I referred will apply to rural and urban pharmacies. Indeed, there is more urban than rural in it, but it will protect rural pharmacies in the way my right hon. Friend mentions.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): The quality system that I have mentioned is about potentially investing more in prevention and linking the best pharmacies—the high quality pharmacies—more closely to local authorities, public health schemes and all that goes with that. I make the point again that there is a requirement for efficiency savings, but we do not believe that they will affect access overall. We do not believe that this will affect the public’s ability to use pharmacies as they do now. This will be part of modernising and digitising the service and providing resources for other parts of the NHS that need them very much.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Alistair James Hendrie Burt (Conservative, Centre-right): Bearing in mind my responsibility for the difficult equation that my hon. Friend has had to solve by coming to the House this morning, I should like to thank him and welcome his statement, which finally brings clarity to these long discussions. Will he repeat very clearly the Government’s absolute commitment to a strong community pharmacy network and to doing all they can to ensure that the NHS delivers on the essential commissioning of quality services? Looking ahead to the future, now that we have got past this, will he ensure that a good review of community pharmacy services is carried out, so that we can see what value they bring to the NHS? I am sure that, like me, he will find that sector extremely valuable to work with.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I thank my right hon. Friend for his fantastic work with the pharmacy sector. He makes the important point that we are trying to move the sector more into services and added value. The two announcements that I made two weeks ago are part of that, as is the work currently being done by Richard Murray from the King’s Fund. That will inform how we spend the integration money and enable the sector to move more quickly into the sorts of services that my right hon. Friend is talking about.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I repeat that we absolutely recognise the vital role that community pharmacies can play, and we want to make them move towards an even more vital role by providing more services, which is what pharmacies want to do, rather than getting all their money from their dispensing activities, as they do at the moment. High quality pharmacies will be in a position to really prosper in the new world that we are talking about.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): The volume of business is gradually increasing. If a pharmacy in a cluster should close, that business will be redirected to other pharmacies in the cluster. They will then be in a position to expand, take on more people and all the rest of it.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I have never said that Leicester has too many pharmacies. What I said in answer to the urgent question was that one road in Leicester—Loughborough Road, I think—has 12 pharmacies within half a mile, and that is quite hard to justify As for the right hon. Gentleman’s other point about diabetes and long-term conditions, I mentioned the King’s Fund work being done by Richard Murray and addressing long-term conditions is the sort of value-added service that pharmacies need to provide in future. The £42 million integration fund that we have set aside will enable that to happen.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Nusrat Munir Ul-Ghani (Conservative, Centre-right): I welcome the news that this Conservative Government are spending £150 million more a year on pharmacies than the last Labour Government and will be paying pharmacies for not only dispensing prescriptions, but their quality of service. In Wealden, pharmacies have the double whammy of being rural and serving an older community, but they provide much-needed services and home deliveries. What news can the Minister share with me that I can share with pharmacies in Wealden?
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): The news that I can share is that pharmacies that are more than 1 mile apart from each other, many of which will exist in rural constituencies such as the hon. Lady’s, will be largely protected under the scheme.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): The King’s Fund study and the £42 million integration fund are directly focused on services and on enabling pharmacies to become more integrated with GPs. In addition, I repeat that 1,500 more clinical pharmacists than we have now will be working for GPs in 2020. That is a huge difference.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Wendy Morton (Conservative, Centre-right): I thank the Minister for coming to the House today and welcome his statement and update. It is right to consider improvements, but in doing so I urge him to ensure that the reforms are part of a broader policy on community pharmacies that seeks better to integrate with the NHS the vital services that they provide.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I give the hon. Lady that assurance. She used the word "integration", which is right at the core of the proposals, as is modernisation. This is a patient-first initiative and we are going to make it happen.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): The scheme that we are putting into place is blind to ownership, so we will not take into account whether a pharmacy is a Boots, a LloydsPharmacy or something smaller. Given the gross margins that are currently being made by the average pharmacy, including smaller ones, I do not believe that the efficiency savings that we are asking for will cause widespread closures. It is scaremongering to imply that.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I do not wholly understand the thrust of that question. I assume that the hon. Gentleman, like others in this House, is welcoming the fact that we are rolling out a national system on ailments, delivered by pharmacists. As the hon. Member for Central Ayrshire (Dr Whitford) said, that is the future.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Helen Olivia Bicknell Whately (Conservative, Centre-right): The Government are right to require pharmacies to make efficiencies, as the NHS is. I welcome the pharmacy access scheme, which I hope will help my local village pharmacies. I urge the Government and NHS England to press ahead with rolling out the minor ailments service, because it is important to make the most of the skills and capacity of pharmacies, in order to provide valuable services to patients and to relieve the burden on GPs.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Martin John Vickers (Conservative, Centre-right): I recognise the difficult decisions the Minister has had to make, but rural pharmacies are going to be particularly hit. He has attempted to sweeten the pill with his access scheme, but it is only a two-year scheme. What support will be forthcoming beyond that?
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): This is the first time ever that we have given pharmacies a two-year planning horizon; usually, these negotiations relate to a one-year period. After the completion of this period, there will be further negotiations, at which point we will take forward what is right to do.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I am not sure that takes us forward, but it is right to say that spending NHS money on payments of £25,000 to many pharmacies within half a mile of one other is the wrong way to spend money when we need more in cancer drugs funds, in GP surgeries and in accident and emergency—that is what we need to be doing.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Edward John Comport Argar (Conservative, Centre-right): A large number of rural villages and small towns in my constituency are served by individual local pharmacies, which play an important role in the community. I welcome the Minister’s comments about the access scheme. Will he reassure me that small pharmacies in rural areas such as mine will be among those to benefit from the access protections he has outlined?
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): Yes, I can reassure my hon. Friend on that. Indeed, I can make the specific point that the 25% that make up the largest pharmacies will not be in the access scheme; it is directed more at smaller pharmacies.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Lucy Claire Leigh (Frazer) (Conservative, Centre-right): The Minister is right to identify that those areas with fewer pharmacies will benefit from protection, not only because the travel time to a pharmacy will be longer, but because the travel time to all support services will be longer. Will he therefore confirm that pharmacies in my rural constituency will benefit from the access scheme?
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): I do not have the specifics for my hon. and learned Friend’s constituency in front of me. We have published the full list and it is in the Vote Office, and I am sure that when she has a look at it she will find that some pharmacies in her area are protected.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
David Mowat (Conservative, Centre-right): Not that I know of, but there may well be. The facts are that the £2.8 billion that we currently spend is for services and for disbursing £8 billion-worth of drugs. It is a valuable service, but it is right that we look to see that that money is spent effectively and as effectively as in other parts of the NHS. It is the Government’s job to make sure that every penny that we give the NHS provides maximum value for patients.
Community Pharmacy in 2016-17 and Beyond — House of Commons, 2016-10-20
Topic: Health
Nigel John Mills (Conservative, Centre-right): May I declare an interest, in that my wife is a community pharmacist? I should therefore probably be cautious in welcoming this statement, for obvious reasons. Will the Minister confirm that the proposals to have a hub-and-spoke model, which would have been even more damaging to community pharmacies, are not part of this step forward?
Economic Growth: Coastal Areas — House of Commons, 2016-11-29
Topic: Defense
Julian William Hendy Brazier (Conservative, Centre-right): I welcome my right hon. Friend’s announcements of the various sums, and may I suggest that the sums the Government have put aside for coastal defence are critical for places such as Whitstable, in my constituency, for generating economic as well as social confidence among the people who live there?
Topical Questions — House of Commons, 2016-11-29
Topic: Health
Questions: As the Chancellor will know, this Saturday marks Small Business Saturday across the country. I will be heading out in Bath to do some Christmas shopping at some of the small businesses and encouraging them to join my Best of Bath business awards. Will he join me in encouraging my constituents, and hopefully my neighbours’ constituents, to come into Bath and shop local?; Casework in Wycombe continues to illustrate calculation and communication errors around tax credit payments. What steps will the Government take to reduce those errors?; Chester’s status as a centre for the financial services industry, particularly FinTech, is under threat from continuing problems with retention by businesses, which cannot get staff to come to the area. Staff cannot get there, because our infrastructure is not good enough. Instead of gloating about the Oxford to Cambridge corridor, can we have some news about when money will be spent on the M56 to upgrade it to a smart motorway?; The autumn statement shows that, as gross national income falls, so will the total projected official development assistance budget. Can the Chancellor assure us that, within that, the Department for International Development budget will be maintained as much as possible and that, if ODA has to contract, cuts will have to fall on other spending Departments before DFID?; A feature of the modern gig economy is that more and more people are sticking together mini jobs, in most of which they earn below the national insurance threshold. HMRC manages to add together that money to tax it, but it does not manage to add together that money to make sure that those people have pensions. What is the Treasury going to do to make sure that older women, in particular, get access to pensions when they have mini jobs?; I am pleased to note that the Chancellor has finally scrapped the arbitrary target for a budget surplus, which would have cut billions more than necessary, but concerns remain about his attitude towards borrowing and debt. Will the Chancellor tell us on what date his charter will come before the House, so that it can be fully scrutinised properly?; Will the Chancellor confirm that the devolution of corporation tax, which is conditional on the Northern Ireland Executive’s finances being on a sustainable footing, is not a vehicle for the Treasury to interfere in Northern Ireland’s devolved policies?
Scott Leslie Mann (Conservative, Centre-right): I welcome my right hon. Friend’s announcement in the autumn statement of £1.7 million of LIBOR money going to Sea Sanctuary to help with mental health provision in Cornwall. Does he agree that that will be a huge help for people all over Cornwall who in the past have had to travel many hundreds of miles to access such services?
Corporate Governance — House of Commons, 2016-11-29
Topic: Health
Gregory David Clark (Conservative, Centre-right): I will indeed. I am delighted that we have had two suggestions from my hon. Friends for this route. I will take them up, and take them seriously. I hope to make further statements to the House in the future Bill Presented Access to Radiotherapy Bill Presentation and First Reading (Standing Order No. 57) Tim Farron presented a Bill to make provision to improve access to radiotherapy treatment in England; to define access in terms of the time that patients are required to travel to places providing treatment; to specify 45 minutes as the maximum time patients are to travel; and for connected purposes Bill read the First time; to be read a Second time on Friday 24 March, and to be printed (Bill 102).
Commonwealth Development Corporation Bill — House of Commons, 2016-11-29
Topic: Health
Priti Sushil Patel (Conservative, Centre-right): As the hon. Gentleman knows from my appearances at the Select Committee, I have clearly stated that I will drive transparency and accountability in the Department. There have been examples. I am sorry that on an issue as important as not only saving lives but transforming lives and investing in people, he chooses to take such a narrow focus.
Commonwealth Development Corporation Bill — House of Commons, 2016-11-29
Topic: Health
Fiona Claire Bruce (Conservative, Centre-right): Does my right hon. Friend agree that with regard to the concerns expressed about the CDC, the gravest relate to the period when the Opposition were in government—for example, the excessive levels of pay to CDC staff? Has the Conservative Government not got a grip of that, and is the CDC not much more efficient following the review in 2012 by the then Secretary of State?
Variant CJD and Surgery — House of Commons, 2016-11-29
Topic: Health
Alexander Paul Beresford (Conservative, Centre-right): The hon. Gentleman makes a good point, but what I would really like to do is get the Government to take some action that is sitting, waiting, readily available to prevent it; otherwise, in time to come I believe we are going to have a chance of a considerable flood of variant CJD disease, but we do not know, and if this test was there we would know if the figure of one in 2,000 is right or wrong, or if we can separate patients out, so that those who have it have special instruments and the rest of us are all right, and we can also start using blood products in this country, because we will only be using products that do not have the prion on board In effect, the Minister needs to think about this: I do not want my grandchildren to be the generation that sees the re-emergence of variant CJD and for them to turn to me, if I am still around, and say, "Why didn’t we do something about it?" That is not a very big ask.
Variant CJD and Surgery — House of Commons, 2016-11-29
Topic: Health
Alexander Paul Beresford (Conservative, Centre-right): I am a little worried that the Minister appears to accept that surgical procedures are as good as they can be, given that the Department is inviting research to find a RelyOn equivalent, to improve the situation. The Department must therefore see a flaw in what we have at present.